Together we can
SAVE LIVES
Since its inception in 1998, the Harry Perkins Institute of Medical Research has made significant discoveries into the diseases that plague our families, in particular heart disease, diabetes, cancer and rare genetic diseases.
With over 270 researchers, scientists and doctors housed in two state-of-the-art research facilities, the Perkins creates a culture of innovation and collaboration. Teams dedicated to finding answers to defeat women’s cancers are funded from the Walk for Women’s Cancer each year.
This is how you're having an impact...
You're supporting
THE WORK OF ASSOCIATE PROFESSOR PILAR BLANCAFORT
By supporting Pilar's fundraising efforts, you are directly contributing to her cutting-edge cancer research. She recently made a groundbreaking discovery of a gene that protects certain breast cancer cells from treatment. With this knowledge, Pilar is exploring new ways to shut off the gene, which could lead to more effective treatments for aggressive cancers and bring us closer to a world free of cancer.
Additionally, her lab made a significant breakthrough in utilizing honeybee venom to effectively eliminate triple-negative breast cancer cells, which are notoriously difficult to treat.
You're backing
DEEPER INVESTIGATION INTO BEE VENOM
Dr. Edina Wang's team is working to improve melittin’s, a key component in honey bee venom) effectiveness by adding components that enhance its ability to target cancer cells. They've found that melittin is highly effective on ovarian cancer cells and are exploring other components of honeybee venom for anti-cancer potential. They've also discovered a protective mechanism in honeybee venom that keeps healthy cells unharmed.
You're funding BRILLIANT MINDS
Each year a researcher receives the New Town Toyota Walk for Women’s Cancer Gift. Given that only 1 in 10 national grants are successful, the Gift ensures that talented researchers can continue finding ground-breaking discoveries for women’s cancer.
Last year’s recipient, Dr Andrew Woo, continues his innovative research in creating personalised treatments to combat Triple Negative Breast Cancer (TNBC) – a very aggressive form of breast cancer. His research focusses on combating TNBC with personalised treatment to lead to better outcomes for our loved ones.
